Daewon Pharmaceutical Co. Ltd. (003220) — Net Asset Quality Index
Daewon Pharmaceutical Co. Ltd. (003220) has a Net Asset Quality Index of 45.5% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of ₩595.99 Billion minus total liabilities of ₩325.01 Billion yields net assets of ₩270.98 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check 003220 strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Quality Index
Net Assets
Total Assets
Total Liabilities
Daewon Pharmaceutical Co. Ltd. Net Asset Quality Index Over Time (2011–2025)
This chart shows how Daewon Pharmaceutical Co. Ltd.'s Net Asset Quality Index has evolved across 15 annual periods from 2011 to 2025. As of March 2026, the index stands at 45.5%, representing net assets of ₩270.98 Billion against total assets of ₩595.99 Billion KRW. Explore how much does Daewon Pharmaceutical Co. Ltd. reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
Annual Net Asset Quality Index for Daewon Pharmaceutical Co. Ltd. (2011–2025)
The table below presents the year-by-year Net Asset Quality Index for Daewon Pharmaceutical Co. Ltd. from 2011 to 2025, covering 15 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market value of Daewon Pharmaceutical Co. Ltd..
| Year | Quality Index | Net Assets (KRW) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 44.7% | ₩274.58 Billion | ₩613.65 Billion | ₩339.07 Billion | ▼ -4.0 pp |
| 2024 | 48.8% | ₩284.58 Billion | ₩583.39 Billion | ₩298.81 Billion | ▼ -3.2 pp |
| 2023 | 52.0% | ₩264.26 Billion | ₩508.00 Billion | ₩243.73 Billion | ▼ -2.8 pp |
| 2022 | 54.8% | ₩248.77 Billion | ₩453.55 Billion | ₩204.78 Billion | ▲ +4.0 pp |
| 2021 | 50.8% | ₩218.40 Billion | ₩429.58 Billion | ₩211.18 Billion | ▼ -12.6 pp |
| 2020 | 63.5% | ₩212.77 Billion | ₩335.21 Billion | ₩122.44 Billion | ▲ +1.1 pp |
| 2019 | 62.3% | ₩204.22 Billion | ₩327.53 Billion | ₩123.32 Billion | ▼ -4.2 pp |
| 2018 | 66.5% | ₩183.20 Billion | ₩275.44 Billion | ₩92.24 Billion | ▼ -7.5 pp |
| 2017 | 74.0% | ₩168.13 Billion | ₩227.20 Billion | ₩59.07 Billion | ▼ -1.5 pp |
| 2016 | 75.5% | ₩162.01 Billion | ₩214.68 Billion | ₩52.67 Billion | ▼ -0.9 pp |
| 2015 | 76.3% | ₩148.66 Billion | ₩194.75 Billion | ₩46.09 Billion | ▲ +1.9 pp |
| 2014 | 74.5% | ₩134.51 Billion | ₩180.62 Billion | ₩46.11 Billion | ▼ -2.5 pp |
| 2013 | 77.0% | ₩123.25 Billion | ₩160.14 Billion | ₩36.89 Billion | ▲ +0.2 pp |
| 2012 | 76.8% | ₩112.92 Billion | ₩147.13 Billion | ₩34.20 Billion | ▲ +2.7 pp |
| 2011 | 74.0% | ₩103.92 Billion | ₩140.39 Billion | ₩36.47 Billion | — |